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Verbascoside (VB) is a bioactive polyphenol from olive oil mill wastewater with known antioxidant activity. Oxidative stress is an
emerging problem in assisted reproductive technology (ART). Juvenile ART is a promising topic because, in farm animals, it reduces
the generation gap and, in human reproductive medicine, it helps to overcome premature ovarian failure. The aim of this study
was to test the effects of VB on the developmental competence of ovine prepubertal oocytes and the bioenergetic/oxidative stress
status of fresh and vitrified oocytes. In fresh oocytes, VB exerted prooxidant short-term effects, that is, catalase activity increase
and uncoupled increases of mitochondria and reactive oxygen species (ROS) fluorescence signals, and long-term effects, that is,
reduced blastocyst formation rate. In vitrified oocytes, VB increased ROS levels. Prooxidant VB effects in ovine prepubertal oocytes
could be related to higher VB accumulation, which was found as almost one thousand times higher than that reported in other cell
systems in previous studies. Also, long exposure times of oocytes to VB, throughout the duration of in vitro maturation culture,
may have contributed to significant increase of oocyte oxidation. Further studies are needed to identify lower concentrations and/or
shorter exposure times to figure out VB antioxidant effects in juvenile ARTs.
1. Introduction
Verbascoside (VB) or acteoside is a phenylpropanoid gly-
coside structurally characterized by the caffeic acid linked
by a 𝛽-(D)-glucopyranoside to 4,5-hydroxyphenylethanol
(hydroxytyrosol) bound through ester and glycosidic links,
with a rhamnose in sequence (1–3) to the glucose molecule.
Verbascoside can be extracted, as other phenolic compounds,
from primary plants, such as olives, but it is also present in a
good amount in olive oil mill wastewater (OMWW), a phyto-
toxic material discarded during olive oil production [1]. For
long time, OMWW has been regarded as a hazardous waste
with negative impact on the environment and an economic
burden on olive oil industry. However, this view has recently
changed to recognise OMWWas a potential low cost starting
material rich in bioactive compounds, particularly phenolic
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compounds, which can be used as natural antioxidants in var-
ious systems [2]. Anti-inflammatory activity of VB has also
been demonstrated by in vitro tests performed on cell cultures
of primary human keratinocytes [3], on the inflammatory
bowel disease in a mouse model [4], and on glioma cell line
(G6) [5]. Other studies demonstrate that VB prevents reactive
oxygen species (ROS) related damages in different ways,
such as by interfering with initial ROS generating reactions,
by scavenging the free oxygen molecules required to begin
ROS production, by chelating metals that speed up oxidative
processes, and by inducing glutathione transferase (GST)
activity [6, 7]. In a recent study, VB antioxidant activity has
been evidenced by using two different bioassays: a cell-free
system, based on in vitro copper (Cu+) induced low density
lipoproteins (LDL) peroxidation, and an in vitro cultured cell
system (HT-29 intestinal cell line), based on the observation
of VB effects on intracellular ROS levels [2].
Oxidative stress occurs if disequilibrium between ROS
production and the antioxidative capacity of the cell takes
place [8]. Reactive oxygen species, such as superoxide anion
(O
2
−) inactivated by the superoxide dismutase (SOD), hydro-
gen peroxide (H
2
O
2
) inactivated by catalase (CAT), and
hydroxyl radical (OH−) inactivated by glutathione peroxidase
(GPX), are oxygen-derived molecules which have the ability
to react with anymolecule andmodify it oxidatively, resulting
in structural and functional alterations. They are not just
damaging by-products of respiration but, at low concentra-
tion, are also important molecules for cell signalling within
intracellular compartments [9]. Reactive oxygen species have
also been implicated in the aetiology of some forms of female
infertility [10]. The effects of ROS on oocytes can be clearly
evidenced in assisted reproductive techniques (ARTS) set-
ting, due to the reduction or lack in the culture environment
of physiological defence mechanisms available in the female
reproductive tract, such as the follicular and oviductal fluids
and cumulus oophorus matrix [11].
A major source for ROS production is the mito-
chondrion, in which they are produced during oxida-
tive phosphorylation [12–14]. Mitochondria are essential
organelles in all eukaryotic cell systems, as the power-
house to provide ATP for a multitude of cellular pro-
cesses. They are the hub of metabolic pathways, primary
sources of ROS, regulators of apoptosis as well as signal
transduction regulators, and buffers of intracellular cal-
cium [15, 16]. Increasing evidences show the essential role
of mitochondria as determinants for developmental com-
petence for human and mammalian oocytes [17–19]. Mito-
chondrial (mt) dysfunctions or abnormalities may compro-
mise developmental processes, by inducing chromosomal
segregation disorders, maturation and fertilization failures,
or embryonic cell fragmentation resulting in mitochondria-
driven apoptosis.Mitochondrial distribution and activity and
oxidative stress status have been analyzed by confocal laser
scanning microscopy (CLSM) in oocytes of several species
[20].
In vitro embryo production (IVP) using oocytes derived
from prepubertal subjects in conjunction with in vitro emb-
ryo transfer, termed as juvenile in vitro embryo transfer
(JIVET), is pursued with the aim of increasing the rate
of genetic gain through a reduction of the generation gap
[21, 22]. Moreover, this technology could be employed in
human ART to preserve female fertility of young adolescent
or paediatric premenarcheal patients affected by cancer or by
different forms of premature ovarian failure [23–25]. Awidely
used animal model for the JIVET research field is the ovine
species, but despite considerable research and great interest in
this technology, the efficiency of JIVET remains low mainly
due to reduced meiotic and developmental competence
of prepubertal oocytes [22, 26]. In addition to biological
concerns, JIVET technology has the need of oocyte cry-
opreservation which still strictly affects prepubertal oocyte
fertilization and developmental competence. Among cryop-
reservation procedures, vitrification, that is, the solidification
of a solution at low temperature, a process achieved by a
combination of a high concentration of cryoprotectants and
an extremely high cooling rate, is an alternative approach to
slow freezing, because it avoids the formation of ice crystals in
the intracellular and extracellular spaces [27–31]. Few papers
have been published to date on vitrification of prepubertal
farm animal oocytes [32–34] as well as in human pediatric
oocytes [35]. Also, few studies on mt bioenergetic potential
of fresh or vitrified prepubertal oocytes have been reported in
farm animals to date [36, 37] but no studies in humans. Lastly,
no data on oxidative stress parameters of prepubertal oocytes
are available in the literature in any species. In this context,
studies aimed to evaluate the potentially antioxidant activity
of natural bioactive compounds, such as phenolic compounds
and polyphenols, present in plant-derived by products would
be beneficial to improve cryopreservation and in vitro culture
protocols of prepubertal oocytes.
The aim of the present study was to test the effects of VB,
added during in vitro maturation (IVM) culture, on oocyte
maturation, cleavage, and blastocyst formation rates of fresh
oocytes and on bioenergetic/oxidative status of fresh and
vitrified oocytes. Moreover, the stability of VB in the IVM
culture system and its absorptive potential by the oocyte-
cumulus complex (OCC) were also assessed.
2. Materials and Methods
All chemicals were purchased from Sigma-Aldrich (Milano,
Italy) unless otherwise indicated.
2.1. Verbascoside Extraction and Purification and HPLC Anal-
ysis. Verbascoside was recovered from OMWW following
the protocol described by Cardinali et al. [1]. Verbascoside
was purified by low-pressure gel filtration chromatography
on a Sephadex LH-20 column (40 cm × 1.6 cm, Pharmacia)
and quantified by High Performance Liquid Chromatog-
raphy with diode array detection (HPLC-DAD) analysis.
Analytical-scale HPLC analyses of VB were performed
using a Thermo Scientific HPLC Spectra System equipped
with a P2000 gradient pump, an SCM1000 vacuum mem-
brane degasser, a UV6000LP diode array UV-VIS detector,
an AS3000 autosampler, and ThermoQuest software. The
ChromQuest Chromatography data system 4.1 version was
used for spectra and data processing. For the HPLC analysis,
an analytical Phenomenex (Torrance, CA) Luna C18 (5𝜇m)
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column (4.6 × 250mm) was used throughout this work.
The solvent system consisted of (A) methanol and (B) acetic
acid/water (5 : 95, v/v). The elution profile was 0–25min 15–
40% A in B (linear), 25–30min 40% A in B (isocratic),
30–45min 40−63% A in B (linear), 45−47min 63% A in
B (isocratic), and 47–51min 63–100% A in B (linear). The
flow rate was 1mL/min. Samples of 25 𝜇L were applied to the
column by means of a 25𝜇L loop valve.
2.2. Oocyte Collection. Ovaries from juvenile (less than 6
months of age) sheep, recovered at two local slaughterhouses,
located at a maximum distance of 20 km (30min) from the
laboratory, were processed by the slicing procedure [38].Only
OCCs with intact cumulus cells layers and a homogeneous
cytoplasm were selected.
2.3. Oocyte In Vitro Maturation. In vitro maturation was
performed following the procedures currently in use in the
two laboratories (Bari and Sassari). Experiments performed
in Sassari aimed to assess the effect of VB exposure during
IVM on oocyte nuclear maturation, cleavage and blastocyst
developmental rates and on the viability of vitrified/warmed
metaphase II (MII) oocytes. Oocytes were cultured in the
conditions described by Bogliolo et al. (Medium 1; [39]).
In vitro maturation was performed in TCM-199, buffered
with 249mM sodium bicarbonate and supplemented with
1.8 𝜇M sodium pyruvate, 10% Oestrus Sheep Serum (OSS),
0.1 IU/mL FSH, 0.1 IU/mL LH, 100𝜇M cysteamine, 0.1 g/L
penicillin, and 0.1 g/L streptomycin. Oocyte-cumulus com-
plexes were cultured in four-well Petri dishes (Nunclon;
Nalge Nunc International, Roskilde, Denmark) covered
with 300 𝜇L preequilibrated mineral oil for 24 h under
5% CO
2
in air at 38.5∘C. Experiments conducted in Bari
aimed to perform confocal microscopy and biochemical
analyses of bioenergetic/oxidative status of fresh and vit-
rified/warmed MII oocytes exposed to VB during IVM
culture and to perform the stability and uptake assays. Ooc-
ytes were cultured as reported by Martino et al. [40] with
some modifications (Medium 2). Medium TCM-199 with
Earle’s salts, buffered with 4.43mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES) and 33.9mMsodium
bicarbonate and supplemented with 0.1 g/L L-glutamine,
2mM sodium pyruvate, 2.92mM calcium-L-lactate pentahy-
drate (Fluka 21175; Serva Feinbiochem), 50𝜇g/mL gentam-
icin, 10% (v/v) Fetal Calf Serum (FCS), 10 𝜇g/mL ovine FSH
and 20𝜇g/mL ovine LH, and 1𝜇g/mL 17 beta estradiol was
used. Oocyte-cumulus complexes were placed in 400 𝜇L of
medium/well of a four-well dish (Nunc Intermed, Roskilde,
Denmark) covered with preequilibrated lightweight paraffin
oil and cultured for 24 h at 38.5∘C under 5% CO
2
in air.
After IVM culture, oocytes underwent cumulus and corona
cells removal by incubation in TCM-199 with 20% FCS
containing 80 IUhyaluronidase/mL and aspiration in and out
of finely drawn glass pipettes. Verbascoside stock solution
(100 𝜇M) was prepared on the day of use by dissolving VB
in distilled water and added in the maturation medium
for the whole duration of IVM culture at three increasing
concentrations (1.03, 2.06, and 4.11 𝜇M) which were reported
as being effective as ROS scavenger [2].
2.4. Oocyte Vitrification. Oocyte vitrification was performed
with the method of minimum essential volume (MEV), as
described by Bogliolo et al. [41]. Briefly, groups of five MII
oocytes were initially equilibrated at 38.5∘C for 1min in
holdingmedium (HM) consisting of 20mMHEPES-buffered
TCM-199 supplemented with 20% (v/v) FCS. After equili-
bration, the oocytes were incubated in 10% (v/v) ethylene
glycol (EG) + 10% (v/v) dimethylsulfoxide (DMSO) in HM
for 30 sec and then transferred to 20% (v/v) EG and 20%
(v/v) DMSO and 0.25M sucrose in HM for 20 s. The oocytes
were then loaded on cryotops (Kitazato Ltd., Tokyo, Japan)
and immediately plunged into liquid nitrogen (LN
2
) for
storage. For warming, cryotops were directly inserted in HM
supplemented with 1.25M sucrose for 1min. Oocytes were
transferred into HM at decreasing sucrose concentrations
(0.62M and 0.31M) and then washed in HM. Warmed
oocytes were cultured for 1 h in TCM-199 supplemented with
10% OSS and their viability was assessed by observation
under a Nikon SMZ 1500 stereomicroscope (60–110x magni-
fication).
2.5. In Vitro Fertilization (IVF) and In Vitro Embryo Develop-
ment. As described by Berlinguer et al. [42], in vitromatured
oocytes were fertilized in Synthetic Oviductal Fluid (SOF,
[43]) + 2% OSS + 1 𝜇g/mL heparin + 1𝜇g/mL hypotaurine
for 22 h at 38.5∘C and under a 5% CO
2
, 5% O
2
, and
90% N
2
atmosphere in four-well Petri dishes with frozen-
thawed spermatozoa selected by swim-up technique (1 ×
106 spermatozoa/mL−1). Presumptive zygotes were cultured
for 8 days in four-well Petri dishes in SOF + essential and
nonessential amino acids at oviductal concentration [44] +
0.4% Bovine Serum Albumin (BSA) under mineral oil, in
maximum humidified atmosphere with 5% CO
2
, 5% O
2
, and
90% N
2
at 38.5∘C.
2.6. Nuclear Chromatin Evaluation of Oocytes and Embryos.
To evaluate nuclear chromatin, at the end of IVM and IVP,
oocytes and embryos were stained with 2.5𝜇g/mL Hoechst
33258 in 3 : 1 (v/v) glycerol/PBS and mounted on microscope
slides covered with cover slips, sealed with nail polish,
and kept at 4∘C in the dark until observation. Oocytes
were evaluated in relation to their meiotic stage under an
epifluorescencemicroscope (Nikon Eclipse 600, 400xmagni-
fication) equippedwith the B-2 A (346 nm excitation/460 nm
emission) filter, as the germinal vesicle (GV), metaphase to
telophase I (MI to TI), MII with 1st polar body (PB) extruded
and degenerated [45]. Embryos were classified as normal
when the presence of a regular shaped nucleus inside each
blastomere was observed [39, 46].
2.7. Oocyte Mitochondria and ROS Staining. After IVM,
additional oocytes showing the 1st PB extruded (MII stage
oocytes) were washed three times in PBS with 3% BSA and
incubated for 30min in the samemedium containing 280 nM
MitoTracker Orange CMTMRos (Molecular Probes M-7510,
Oregon, USA) at 38.5∘C under 5% CO
2
[20, 40, 47]. The
cell-permeant probe contains a thiol-reactive chloromethyl
moiety. Once the MitoTracker probe accumulates in the
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mitochondria, it can react with accessible thiol groups on
peptides and proteins to form an aldehyde-fixable conjugate.
This cell-permeant probe is readily sequestered only by active
mitochondria [48, 49]. The organelle specificity of the probe
was assessed, as reported by Valentini et al. [50], in control
oocytes which were imaged after incubation in MitoTracker
Orange and further incubation for 5min in the presence
of 5 𝜇M of the mt membrane potential (Delta Psi) collaps-
ing uncoupler carbonyl cyanide 3-chloro phenyl hydrazone
(CCCP; Molecular Probes), which inhibits mt respiratory
activity, thus reducing fluorescence intensity. After incuba-
tion with mt probe, oocytes were washed three times in PBS
with 0.3% BSA and incubated for 15min in the same media
containing 10 𝜇M 2󸀠,7󸀠-dichlorodihydrofluorescein diacetate
(H
2
DCF-DA) [51, 52] in order to detect and localize intracel-
lular sources of ROS.The principle underlying this procedure
may be described briefly as follows: nonionized H
2
DCF-
DA is membrane permeant and therefore is able to diffuse
readily into cells. Once within the cell, the acetate groups
are hydrolysed by intracellular esterase activity forming 2󸀠,7󸀠-
dichlorodihydrofluorescein (H
2
DCF)which is polar and thus
trapped within the cell. H
2
DCF fluoresces when it is oxidized
by H
2
O
2
or lipid peroxides to yield 2󸀠,7󸀠-dichlorofluorescein
(DCF). The level of DCF produced within the cells is related
linearly to that of peroxides present and thus its fluorescent
emission provides a measure of the peroxide levels [51]. After
incubation, oocytes were washed three times in prewarmed
PBS without BSA and fixed overnight at 4∘C with 2%
paraformaldehyde solution in PBS.
2.8. Assessment of Oocyte Mitochondrial Distribution Pattern
and Intracellular ROS Localization. For mt distribution pat-
tern evaluation, MII oocytes were selected among those hav-
ing regular ooplasmic size and texture (no vacuoles). Oocytes
were observed at 600x magnification in oil immersion with
Nikon C1/TE2000-U laser scanning confocal microscope. A
helium/neon laser ray at 543 nm and the G-2 A filter (551 nm
exposure and 576 nm emission) were used to point out the
MitoTracker Orange CMTM Ros. An argon ions laser ray at
488 nm and the B-2 A filter (495 nm exposure and 519 nm
emission) were used to point out the DCF. Scanning was
conducted with 25 optical series from the top to the bottom
of the oocyte with a step size of 0.45 𝜇m to allow three-
dimensional distribution analysis. General criteria for oocyte
mt patterns definition were adopted on the basis of previous
studies in other species [20, 40, 47, 50]. Homogeneous/even
distribution of small mt aggregates throughout the cytoplasm
was considered as indication of immature cytoplasmic con-
dition, whereas heterogeneous/uneven distribution of small
and/or large aggregates within the cytoplasm indicated a
metabolically active ooplasm. In particular, accumulation
of mitochondria in the peripheral cytoplasm and around
the nucleus was considered as aspects of the developmental
program of cytoplasmic maturation [53]. Oocytes showing
irregular distribution of large mt clusters unrelated to the
specific cell compartments were classified as abnormal. To
our knowledge, few studies are reported to date on intracel-
lular ROS localization in mammalian oocytes. Recent studies
performed inmouse [54], equine [47], and ovine [40] oocytes
from adult females reported mt/ROS colocalization as a
biomarker of healthy oocytes.
2.9. Quantification of MitoTracker Orange CMTM Ros and
DCF Fluorescence Intensity. Measurements of fluorescence
intensities were performed in MII oocytes having either
heterogeneous (perinuclear and/or pericortical) or homoge-
neous (small aggregates) mt distribution pattern. Oocytes
showing abnormal mt distribution pattern were excluded
from this analysis. In each individual oocyte, MitoTracker
and DCF fluorescence intensities were measured at the equa-
torial plane, as in previous studies fromour unit performed in
human [55] and animal oocytes [20, 40, 47, 50], with the aid of
the EZ-C1GoldVersion 3.70 image analysis software platform
for Nikon C1 (Nikon Instruments) confocal microscope. A
circle of an area = 100 in diameter (arbitrary value) was drawn
to measure only the cytoplasmic area (512 × 512 pixels). The
fluorescence intensity encountered within the programmed
scan area was recorded and plotted against the conventional
pixel unit scale (0–255). Fluorescence intensity was expressed
as arbitrary densitometric units (ADU). Parameters related
to fluorescence intensity were maintained at constant values
for all measurements. In detail, images were taken under
fixed scanning conditions with respect to laser energy, signal
detection (gain), and pinhole size.
2.10. Oocyte Mitochondria/ROS Colocalization Analysis. Col-
ocalization analysis ofmitochondria and ROSwas performed
by using the EZC1GoldVersion 3.70 software.Degree of colo-
calization was reported as Pearson’s correlation coefficient
quantifying the overlap degree between MitoTraker Orange
CMTM Ros and DCF fluorescence signals [40].
2.11. Measurement of the Total CAT Activity in Single Oocytes.
Additional MII oocytes were washed in SB buffer (TRIS/HCl
60mM pH 6.8, Glycerol 40%) and individually solubilized
for one hour at 4∘C in the presence of 1.0% Triton X-100.
The protein concentration was assessed by the method of
Bradford [56]. Each test was performed on 7𝜇g of proteins
from a single solubilized oocyte. The CAT activity was
determined following the Beers and Sizer method [57]. A
spectrophotometerVarianCaryWinUV50was used to follow
the absorbance decrease at 240 nm in the presence of H
2
O
2
for time unit, in potassium-phosphate 50mM, EDTA 1mM
pH 7.0, at 25∘C, in a final volume of 1mL. After determin-
ing the baseline with the measure mixture, 3.5mM H
2
O
2
was added. Reaching stability, the reactions with protein
extract started. Since H
2
O
2
molar extinction coefficient (𝜀
= 40M−1 ∗ cm−1) is known, CAT activity was calculated
as 𝜇moles of H
2
O
2
converted in H
2
O per minute. Specific
activities were calculated by dividing enzymatic activities per
total protein concentration expressed in mg.
2.12. Measurement of the Total SOD Activity in Single
Oocytes. Additional MII oocytes were washed in SB buffer
(TRIS/ HCl 60mM pH 6.8, Glycerol 40%) and individually
solubilized for one hour at 4∘C in the presence of 1.0% Tri-
ton X-100. The protein concentration was assessed by the
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method of Bradford [56]. Each test was performed on 7𝜇g
of proteins of a single solubilized oocyte. SOD activity
was determined with the Fluka analytical assay kit using a
multiplate reader Victor X, Perkin Elmer at 𝜆 = 440 nm.
Total SOD activity (SOD, EC 1.15.1.1) was assayed by its
ability to inhibit the reduction of a novel tetrazolium salt,
WST-1[2-(4-Iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfop-
henyl)-2H-tetrazolium, monosodium salt] by superoxide
anions generatedwith the xanthine/xanthine oxidasemethod
[58, 59]. One unit of SOD activity was defined as the amount
of the enzyme causing half maximum inhibition of WST-1
reduction. It was measured with high sensitivity (0.01 pmol)
and expressed as U/mg proteins. A nine-point standard
curve was routinely included in each assay.
2.13. Verbascoside Stability in Oocyte-Free Culture Medium
and Its Uptake by the OCC. Verbascoside stability in the IVM
culture medium was assessed in the same conditions as that
used in IVM experiments. In particular, VB (10𝜇M) was
added to the maturation medium in the absence of oocytes
for 24 h at 38.5∘C. After 0, 4, 12, and 24 h, aliquots of the
mixed solutions were analyzed by HPLC-DAD as described
in HPLC analysis section. For accumulation experiments,
OCCs were cultured in maturation medium containing
100 𝜇M VB. Oocytes were then incubated at 38.5∘C for 30
and 60min. Following incubation, media were aspirated and
stored at −80∘C until analysis; oocytes were washed 3 times
with PBS (pH 7.4) then were collected and stored at −80∘C
until analysis. Protein values for each tested oocyte pool
(𝑛 = 2 pools of 36 OCCs each) were assessed by Bio-Rad
protein assay method [56] and were found to be 0.504 ±
0.05mg of total protein/pool. Verbascoside was extracted
from sonicated OCCs with 3mL of ethyl acetate (0.01%
butylated hydroxytoluene) for three times. Ethyl acetate lay-
ers were pooled, dried under vacuum, and resolubilized in
300 𝜇L ofHPLCmobile phase. HPLC analysis was performed
following the protocol as described before.
2.14. Statistical Analysis. Oocyte nuclear maturation rates,
cleavage and blastocyst developmental rates, and the percent-
ages of oocytes showing different mt and intracellular ROS
distribution patterns were compared between treated and
control groups by Chi-square test with the Yates correction
for continuity. The effects of VB on nuclear maturation rates
were also assessed by multifactor ANOVA, taking into acco-
unt the use of the two IVM media. Fisher’s exact test was
applied in all cases in which at least one cell contained a
value less than 5. For confocal quantification analysis of mt
activity and intracellular ROS levels, the least-square means
of the dependent variable (MitoTracker CMTM Ros and
DCF fluorescence intensity) were calculated in examined
samples and the statistical significance of the least-square
means between treated and control groups was calculated
by one-way ANOVA followed by Multiple Comparison
Dunn’s method (SigmaPlot software). For mt/ROS colo-
calization, mean values of Pearson’s correlation coefficient
were compared between treated and control groups by
one-way ANOVA followed by Multiple Comparison Dunn’s
method (SigmaPlot software). CAT and SOD activities were
compared between treated and control groups by Student’s t
test. Differences with𝑃 < 0.05were considered as statistically
significant.
3. Results
3.1. Verbascoside Extraction and Purification and HPLC Anal-
ysis. Verbascoside was purified from OMWW by using a
laboratory scale system to remove solid particles from the
fluid and to fractionate molecules with different molecular
weight. From the two permeate fractions obtained, micro-
filtrate (MF) and ultrafiltrate (UF), UF was considered to be
around 50% of the initial volume of OMWW (5 L of UF from
10 L of OMWW). This fraction was subsequently separated
by low-pressure gel filtration chromatography on a Sephadex
LH-20 column to give a highly purified VB fraction. The
concentration of VB obtained was on average 3.25mg/30mL
of UF giving a final yield of around 54mg of VB from
each liter of OMWW. Purification degree for VB, calculated
on peak area, was around 95% as demonstrated by HPLC
analysis.
3.2. Verbascoside Did Not Affect the Nuclear Maturation
Rate of Fresh Prepubertal Lamb Oocytes. One thousand and
twenty-nine oocytes were recovered, 850 of which were sur-
rounded by a healthy cumulus and were selected for IVM
culture. Oocytes were cultured in IVM medium 1 or in IVM
medium 2. For each medium, five consecutive trials were
performed. In Table 1, separated and pooled data obtained
with both culture media are presented. Verbascoside did not
affect thematuration rate of prepubertal lamb oocytes neither
when added in medium 1 nor when added in medium 2. No
effects were also noticed in pooled data of oocytes matured in
medium 1 + medium 2.
On the other hand, within each medium and at specific
tested VB concentrations (2.06 and 4.11 𝜇M), an indirect
beneficial influence of medium 1 composition on the VB
effects on oocyte meiosis resumption and progression to the
MII stage was noticed. In oocytes cultured in presence of
2.06 𝜇M VB, a significantly higher rate of those cultured in
medium 1 resumed meiosis (significantly lower rate of GV
oocytes; 𝑃 < 0.001) and reached the metaphase stages (𝑃 <
0.001) comparedwith those cultured inmedium 2. In oocytes
cultured in presence of 4.11 𝜇M, a significantly lower rate of
GV oocytes (𝑃 < 0.001) was found and thematuration rate to
theMII stage tended to be higher (𝑃 = 0.054) compared with
those cultured in medium 2. Thus, possibly, the VB effects
may differ in oocytes primed by different media. The multi-
factor ANOVA analysis confirmed Chi-square based signifi-
cances.
3.3. Verbascoside Impaired the Blastocyst Formation Rate of
Fresh Prepubertal Lamb Oocytes. Nine hundred MII oocytes
were used for IVF and in vitro embryo culture experiments.
Early cleavage and blastocyst formation rates were recorded
as resumed in Table 2. After IVF, for each condition, the num-
ber of cleaved oocytes at 24 and 30 hours after fertilization
and the number of embryos reaching the blastocyst stage at
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Table 1: Effects of verbascoside on the in vitromeiotic maturation of prepubertal lamb oocytes.
Verbascoside concentration (𝜇M) Number of cultured oocytes IVMmedium type Nuclear chromatin configuration number (%)
GV MI to TI MII + PB Degenerated
0
93 1 9 (9.7)c 6 (6.5) 59 (63.4) 19 (20.4)a
111 2 27 (24.3)d 17 (15.3) 60 (54.1) 7 (6.3)b
204 (∗) 36 (17.6) 23 (11.3) 119 (58.3) 26 (12.7)
1.03
79 1 11 (13.9) 12 (15.2) 44 (55.7) 12 (15.2)
118 2 27 (22.9) 21 (17.8) 61 (51.7) 9 (7.6)
197 (∗) 38 (19.3) 33 (16.8) 105 (53.3) 21 (10.7)
2.06
98 1 12 (12.2)c 6 (6.1)a 67 (68.4)c 13 (13.3)
116 2 33 (28.4)d 21 (18.1)b 50 (43.1)d 12 (10.3)
214 (∗) 45 (21) 27 (12.6) 117 (54.7) 25 (11.7)
4.11
98 1 11 (11.2)c 13 (13.3) 58 (59.2) 16 (16.3)
137 2 36 (26.3)d 23 (16.8) 63 (46) 15 (10.9)
235 (∗) 47 (20) 36 (15.3) 121 (51.5) 31 (13.2)
GV: germinal vesicle, M: metaphase, T: telophase, and PB: polar body. ∗Pooled data of oocytes cultured in medium 1 + medium 2. Chi-square test and
multifactorANOVA test: within eachmedium type and pooled data, VB-treated versus controls: NS; betweenmedia, within eachVB concentration: a,b𝑃 < 0.05;
c,d
𝑃 < 0.001.
Table 2: Effects of verbascoside on cleavage and blastocyst developmental rates of prepubertal lamb oocytes after IVF and IVP.
Verbascoside concentration (𝜇M) Number of MII oocytes Number of cleaved embryos (%) Number of blastocysts (%)
24 h after-IVF 30 h after-IVF At day 7 At day 8
0 200 76 (38) 150 (75) 28 (18.7)a 36 (24)a
1.03 240 103 (42.9) 189 (78.7) 38 (20.1) 59 (31.2)
2.06 220 77 (35) 156 (70.9) 18 (11.5) 18 (11.5)b
4.11 240 93 (38.7) 185 (77.1) 11 (5.9)b 22 (11.9)b
Chi-square test: a,b𝑃 < 0.05.
Table 3: Effects of verbascoside on the mitochondrial distribution pattern of in vitromatured prepubertal lamb oocytes.
Verbascoside
concentration (𝜇M)
Number of MII
oocytes
Mitochondrial distribution number (%)
Homogeneous Heterogeneous Abnormal
Total
(1 + 2 + 3)
Perinuclear/
pericortical (1)
Peri-nuclear
(2)
Peri-cortical
(3)
0 30 16 (53.3) 14 (46.7) 0 (0) 2 (6.7) 12 (40) 0 (0)
1.03 29 15 (51.7) 12 (41.4) 1 (3.4) 2 (6.9) 9 (31) 2 (6.9)
2.06 25 16 (64) 9 (36.0) 1 (4) 2 (8) 6 (24) 0 (0)
4.11 29 13 (44.8) 16 (55.2) 0 (0) 2 (6.9) 14 (48.3) 0 (0)
Chi-square test: NS.
day 7 and day 8 were recorded. No significant differences
in the early cleavage rate were found between VB-treated
and control groups. Significant reductions of the blastocyst
formation rate were found in the group of oocytes exposed
to 2.06 and 4.11 𝜇MVB compared with controls (Table 2; 𝑃 <
0.05).
3.4. Verbascoside Did Not Affect mt Distribution Pattern and
Intracellular ROS Localization of Fresh MII Stage Prepubertal
Lamb Oocytes. One hundred and thirteen fresh oocytes
matured in vitro and found at the MII stage were analyzed.
No significant effects of VB on mt distribution pattern of
fresh prepubertal lambMII stage oocyteswas found (Table 3).
Intracellular ROS localization was also unaffected by VB and
data concerning this parameter corresponded to data of mt
distribution pattern presented in Table 3.
3.5. Verbascoside, at the Highest Tested Concentration,
Increased mt Activity and ROS Levels inMII Fresh Prepubertal
LambOocytes. Asignificant increase inmt activitywas found
in oocytes treatment groups exposed to the highest VB
concentration (4.11𝜇M) compared with controls (Figure 1(a),
𝑃 < 0.05). No variations were found, at the lower concen-
trations assessed. As well, in the 4.11𝜇M VB exposed group,
a significant increase in intracellular ROS levels was found
comparedwith controls (Figure 1(b),𝑃 < 0.001).Themt/ROS
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Figure 1: Dose response curve of the in vitro effects of VB on
mt activity and intracellular ROS levels in single fresh prepubertal
lamb MII stage oocytes, expressed as MitoTracker Orange CMTM
Ros (panel (a)) and DCF (panel (b)) fluorescence intensities.
Oocytes treated with 4.11𝜇M VB showed significantly higher mt
activity and intracellular ROS levels compared with controls. Values
are expressed as ADU (arbitrary densitometric units). Pearson’s
correlation coefficients of MitoTracker Orange CMTM Ros and
DCF fluorescent labelling colocalization of treated versus control
MII oocytes (panel (c)). Numbers of analyzed oocytes per group are
indicated at the bottom of each histogram. (a) One-way ANOVA: a,
b: 𝑃 < 0.05; (b) one-way ANOVA: a, c: 𝑃 < 0.001; and (c) one-way
ANOVA: NS (not significant).
colocalization, expressed as Pearson’s correlation coefficient,
was not affected by VB addition (Figure 1(c), NS). Figure 2
shows mt distribution pattern and activity, intracellular ROS
localization and levels, andmt/ROS colocalization of a repre-
sentative control MII oocyte (Figure 2(a)) and a MII oocyte
representative of those cultured in presence of 4.11𝜇M VB
(Figure 2(b)). Increased MitoTracker and DCF fluorescence
intensities, indicating mt activity and ROS levels, are evident
in the VB-treated oocyte compared with the control one.
3.6. Verbascoside Affected CAT but Not Total SOD Activity in
MII Fresh Prepubertal Lamb Oocytes. Scavenging enzymes,
CAT and SOD, activities were evaluated on freshMII oocytes.
CAT activity assay was conducted on individual oocytes
(𝑛 = 64) that showed the 1st PB extruded after IVM. For
SOD activity assay, 41 individual MII oocytes were evaluated.
Table 4: Postvitrification/warming viability of prepubertal lamb
oocytes matured in vitro in presence of verbascoside.
Verbascoside
concentration (𝜇M)
Number of MII
oocytes
vitrified/warmed
Viability
number (%)
0 55 28 (50.9)
1.03 41 28 (68.3)
2.06 55 37 (67.3)
4.11 58 29 (50.0)
Chi-square test: NS.
Results are reported in Figure 3. Significant increase of CAT
activity in VB-treated groups was observed compared with
controls (Figure 3(a); 𝑃 < 0.05). On the contrary, SOD
activity was not affected by VB addition and constant levels
were found at any tested concentration (Figure 3(b), NS).
3.7. Verbascoside Did Not Affect Oocyte Viability in MII Vit-
rified/Warmed Prepubertal Lamb Oocytes. Oocytes cultured
in vitro in presence of different VB concentrations and found
at the MII stage were vitrified/warmed and analyzed for
cell viability. Oocyte viability assessment, expressed as the
percentage of oocytes showing zona pellucida and oolemma
integrity and absence of ooplasmic cyto-fragmentation, was
conducted on 209 vitrified/warmed oocytes. No significant
effects of VB on oocyte viability after vitrification/warming
were observed (Table 4).
3.8. Verbascoside Did Not Affect mt Distribution Pattern and
ROS Intracellular Localization in MII Vitrified/Warmed Pre-
pubertal LambOocytes. Oocytes cultured in vitro in presence
of different VB concentrations and found at the MII stage
were vitrified/warmed and analyzed for confocal parameters
expressing the bioenergetic/oxidative status. Sixty-six vitri-
fied/warmed oocytes were analyzed. Verbascoside did not
affect the mt distribution pattern in MII vitrified/warmed
prepubertal lamb oocytes (Table 5). Intracellular ROS local-
ization also did not vary upon VB addition in vitrified
samples and data concerning this parameter corresponded to
those presented in Table 5, as previously observed for fresh
oocytes.
3.9. Verbascoside Did Not Affect mt Activity but Increased
ROS Levels in MII Vitrified/Warmed Prepubertal Lamb
Oocytes. Concerning mt activity, no significant difference
was observed in the comparisons between treated and control
groups (Figure 4(a), NS). Intracellular ROS levels increased
in the group of oocytes treated with the low VB concen-
tration (1.03 𝜇M) compared with controls (Figure 4(b), 𝑃 <
0.001). In vitrified/warmed oocytes, mt/ROS colocalization,
expressed as Pearson’s correlation coefficient, was not affected
by VB addition (Figure 4(c)).
3.10. Low Verbascoside Stability in Oocyte IVM Culture
Medium. As shown in Figure 5, after 4 hours of exposure, VB
concentration decreased about 55.6% with respect to the
initial amount; moreover, the presence of an isomerisation
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(a) (b)
Figure 2: Mitochondrial distribution pattern and activity, intracellular ROS localization and levels, and mt/ROS colocalization of a
representative prepubertal lamb control MII oocyte (panel (a)) and a MII oocyte representative of those cultured in presence of 4.11𝜇M
VB (panel (b)). Both oocytes show heterogeneous mt pattern. For each culture condition, corresponding bright-field (A1, B1), UV light (A2,
B2), and confocal laser scanning images of mt distribution pattern (A3, B3), intracellular ROS localization (A4, B4), mt/ROSmerge (A5, B5),
and colocalization scatterplot graph (A6, B6) are shown. Increased mt activity, expressed as MitoTracker Orange CMTM Ros fluorescence
intensity, and intracellular ROS levels, expressed as DCF fluorescent intensity (B4), can be seen in the oocyte exposed to 4.11𝜇MVB compared
with the control oocyte (B3 versus A3 and B4 versus A4, resp.). Scale bars represent 50𝜇M.
Table 5: Post vitrification/warming mitochondrial distribution pattern of prepubertal lamb MII oocytes obtained after IVM in presence of
verbascoside.
Verbascoside
concentrationNumber of MII oocytes
Mitochondrial distribution pattern number (%)
Homogeneous Heterogeneous Abnormal
Total
(1 + 2 + 3)
Peri-nuclear/peri-cortical
(1)
Peri-nuclear
(2)
Peri-cortical
(3)
0 (control) 15 8 (53.3) 7 (46.7) 0 (0) 2 (13.3) 5 (33.3) 0 (0)
1.03 18 11 (61.1) 6 (33.3) 2 (11.1) 1 (5.6) 3 (16.7) 1 (5.6)
2.06 19 14 (73.7) 5 (26.3) 0 (0) 0 (0) 5 (26.3) 0 (0)
4.11 14 10 (71.4) 4 (28.6) 0 (0) 2 (14.3) 2 (14.3) 0 (0)
Chi-square test: NS.
product was recorded. In fact, at this time point, its positional
isomer, isoverbascoside (isoVB) of occurred in the propor-
tion of 20% to the total. After 12 h with exposure in oocyte-
free medium, further reduction of VB concentration, by 80%
with respect to the initial amount, was found. Verbascoside
and its positional isomer isoVB, at this time, were present
with the same proportions. After 24 hours, no traces of
both polyphenols were recovered. No specific degradation
products were characterized beyond isoVB.
3.11. Rapid Verbascoside Uptake in Prepubertal Lamb OCCs.
To evaluate absorptive potential of the OCC, VB accumula-
tion experiments were conducted on two groups of 36 OCCs
each, one examined at 30min and the other examined at
60min after the start of exposure. Uptake of VB was found to
be time dependent and reached the maximum at 30min after
start of exposure. At 100𝜇M,OCCs accumulated 79.4 nmol of
VB/mg of OCCs proteins. It represents approximately 0.2%
of absorption of the tested VB. At 60min, VB accumulated
by the OCCs decreased to 19.05 nmol of VB/mg of OCCs
proteins.
4. Discussion
The highly purified VB from OMWW was previously ana-
lyzed for assessing its antioxidant activity and, after brief
incubation in HT-29 cell line, it showed antioxidant prop-
erties [2]. However, at the typical conditions used in the
present study, VB showed an opposite behavior. In fact, this
compound had no effect on oocyte nuclear maturation rate.
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Figure 3: Catalase (CAT) and total superoxide dismutase (SOD)
activities in individual prepubertal lamb MII oocytes matured in
vitro in presence of VB. Numbers of analyzed oocytes per group are
indicated at the bottom of each histogram. Values are expressed as
IU/mg protein. Treatment with VB induced a significant increase in
CAT activity compared to controls (panel (a); Student’s t-test: a, b;
𝑃 < 0.001). Total SOD activity did not vary between treated and
control groups (panel (b); Student’s t-test: NS).
IVM data obtained with media 1 and 2 were kept separated in
order to avoidmisinterpretation due to the effects of different
culture conditions. In both testedmedia, no significant differ-
ences were noticed between VB-treated and control oocytes.
Moreover, a reduction of the blastocyst formation rate after
exposure to intermediate and high VB doses was found.
This result can be considered as a long-term effect of VB or
VB derived products on oocyte cytoplasmic competence and
consequently on embryo development.These findings lead us
to hypothesize that, in our cell system, VB had an oxidatively
stressful and toxic effect probably as a consequence of a
prolonged exposure time at the tested concentrations or
toxicity resulting from oxidative degradation of VB and
subsequent generation of H
2
O
2
as reported for oxidation of
phenolic compounds in culture media [60]. This observation
is interesting considering that the concentrations used in
these studies were reported as being effective in modulating
oxidative stress in HT29 cell line after brief (30min) in vitro
exposure [2].
In order to investigate the reasons of the observed com-
promised embryo development, we investigated the bioen-
ergetic potential and oxidative status of oocytes exposed to
VB. The supplementation of the IVM medium with VB did
not change mt distribution pattern and intracellular ROS
localization in prepubertal lamb oocytes. However, in the
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Figure 4: Dose response curve of the in vitro effects of VB, added
during IVM culture, on mt activity and intracellular ROS levels
in single prepubertal lamb MII stage oocytes vitrified/warmed,
expressed as MitoTracker Orange CMTM Ros (panel (a)) and DCF
(panel (b)) fluorescence intensities. Oocytes treated with 1.03𝜇M
VB showed significantly higher intracellular ROS levels compared
with controls. Values are expressed as ADU (arbitrary densitometric
units). Pearson’s correlation coefficients of MitoTracker Orange
CMTM Ros and DCF fluorescent labelling colocalization in MII
oocytes obtained after IVM culture in presence of VB and vitri-
fied/warmed (panel (c)). Numbers of analyzed oocytes per group are
indicated at the bottom of each histogram. (a) One-way ANOVA:
NS. (b) One-way ANOVA: a,b: 𝑃 < 0.001. (c) One-way ANOVA:
NS.
group of oocytes exposed to the highest VB concentration,
it increased mt activity and intracellular ROS levels without
affecting mt/ROS colocalization. This finding allowed us to
consider that the two fluorescence signals were not over-
lapping; thus observed ROS increase could be not only due
to mt ROS generation, rather it could be also of cytosolic
origin, thus indicating a stressed/toxic cytoplasmic condition.
In fact, high levels of mt/ROS colocalization were reported as
a reliable marker of healthy MII oocytes [40]. In the culture
conditions (VB exposure times and tested concentrations) of
this study, the ooplasmic bioenergetic/redox status was not
improved by VB addition, as confocal analysis stated that VB,
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Figure 5: Stability test ofVB in oocyte-free IVMmedium, incubated
at 38.5∘C under 5% CO
2
in air. The figure shows the decrease of
VB versus time. isoVB appears after 4 hours of incubation. After 24
hours, both VB and isoVB are not detected.
at the tested concentrations, failed to behave as an antioxidant
compound, a role which was previously demonstrated in
other cell line system [2, 3, 6, 7]; rather it demonstrated a
prooxidant effect.
To provide further information about the effects of VB
on oocyte cytoplasm oxidative status, the activities of two
scavenging enzymes, CAT and SOD, in VB exposed oocytes
were tested.The assays demonstrated that while SOD activity
was not affected, CAT activity significantly increased upon
VB addition. This increase could be due to the potential
formation of H
2
O
2
during oxidation of phenolics in cell
culturemedia. Verbascoside stability was observed to be poor
in the conditions tested (Figure 5). Oxidative degradation of
phenolic compounds has been reported to proceed through
auto-oxidative mechanism involving formation of H
2
O
2
[61,
62]. This increase in peroxides would explain the subsequent
increase in CAT activity without an increase in SOD activity.
The observed lack of variation of SOD activity may also be
related to the fact that, in our experiments, total SOD activity
was investigated. It cannot be excluded that the relative ratio
between cytosolic and mt SOD could be varied upon VB
addition, but further studies are necessary to address this
hypothesis.The stimulating effect of VB on CAT activity may
also be related to the observed increase in intracellular ROS
levels. Moreover, it can be interpreted under the light of cur-
rent literature. In fact, recent in vivo and in vitro studies report
different effects of VB on the antioxidant enzyme network [6,
63–65]. Other studies show that VB increased the expression
of the transcription factor peroxisome proliferator activated
receptor 𝛼 (PPAR-𝛼) in nuclear extracts of colon cells [4].
Another member of PPARs family, PPAR𝛾, has been shown
to activate genes with a peroxisome proliferator response
element (PPRE) in their promoter regions [66]. Indeed, the
CAT promoter gene is known to contain functional PPAR-
𝛾 responsive elements, so it is possible that the CAT activity
could be regulated by PPAR-𝛾 agonists [67, 68]. Based on our
results and these observations, it is possible to hypothesize
that VB may act by increasing oocyte intracellular ROS
levels, both by generating H
2
O
2
through its own oxidative
degradation and by increasingCAT expression levels through
multiple mechanisms.
As a further step of the JIVET technology and due
to the particular interest of establishing suitable cryoprese-
rvation procedures allowing the prepubertal oocyte to be
protected against cryodamage, the effects of VB added dur-
ing IVM on the viability and bioenergetic/oxidative status
of MII vitrified/warmed oocytes were evaluated. Exposure
to high cryoprotectant concentrations and subphysiological
temperature generates in the oocyte a widespread oxidative
stress, as reported by Zhao et al. [69]. Moreover, Succu et al.
[34] demonstrated that prepubertal oocytes are more susce-
ptible than adult counterparts to cryoinjury during vitrifi-
cation performing. No effects of VB on cell viability para-
meters of vitrified/warmed oocytes were found. In order
to provide additional information on cytoplasmic condition
after vitrification/warming, we investigated the effects of
VB on the bioenergy/oxidative status of vitrified/warmed
oocytes. Just like in fresh oocytes, VB did not affect mt distri-
bution pattern, ROS localization, and mt activity of vitrified
oocytes. However, when used at the lowest tested conce-
ntration (1.03 𝜇M) during IVM, it increased ROS levels
without affecting mt/ROS colocalization. This finding can be
explained considering that, in the case of vitrified oocytes
(a more stressed cell system compared to their fresh coun-
terpart), the prooxidant toxic effect of VB could have been
strengthened, as supported by the comparison between fresh
and vitrified oocytes at 1.03 𝜇MVB (𝑃 = 0.002).
In the light of obtained results and considering that
it is well known that, for every drug, the line between
benefit and toxicity is represented by the administered dose,
differences in the cellular metabolism, dimension, and num-
ber of cells per dish between oocytes and cultured cell lines
leading to differences in drug uptake which may result as
a beneficial or toxic concentration to the cell were hypo-
thesized. For these reasons, we performed experiments to
test (1) VB stability in our culture conditions and (2) its
uptake by the OCCs. Determinations of VB stability in an
oocyte-free IVM medium at 38.5∘C indicated that VB was
unstable under our IVM culture conditions, as previously
reported [70], also for other polyphenols such as catechin,
chlorogenic acid [60, 71–73]. After 4 hours of incubation, an
isomerization process occurred, with the appearance of the
positional isomer, isoVB. This process is probably related to
the medium pH (7.2–7.4) and culture temperature (38.5∘C)
or to the deacetylation and VB caffeoyl moiety migration
under hydrolytic environment of harsh extraction conditions
[74]. After 12 hours, the residual percentage of VB and isoVB
was 20% and reached zero after 24 hours of incubation.
Probably, other products derived fromoxidation activitywere
present but, at this point of the research, no information
about these products is available.These data are in agreement
with the results obtained from other polyphenols that were
also unstable under the incubation conditions used [71].
Moreover, VB uptake experiments demonstrated that the
compound was rapidly incorporated into the OCCs in a
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time-dependent manner with an accumulation efficiency of
about 0.2% after 30min.This observed low level of VB uptake
was similar to that reported for HT-29 and Caco-2 human
intestinal cells [2, 75] and for other polyphenols such as
catechins [76–78] and is consistent with poor in vivo VB
bioavailability, as reported by Funes et al. [79] following oral
administration of lemon verbena extract in rodents and by
Cardinali et al., [80] with ex vivo experiments. The uptake
experiments by OCCs also demonstrated that the amount of
VB in our cells was one thousand times higher (in the order of
nmol/mg proteins) than that found in the Caco-2 and HT 29
human intestinal cell lines (in the order of pmol/mg proteins)
by Cardinali et al. [2, 75]. This result could be consistent
with the observed prooxidant activity of VB in the current
model. Future experiments should consider lower levels of
VB exposure to better emulate intracellular concentrations
observed in other cell models and to better understand if
lower levels may be able to deliver differential protection
against oxidative stress.
Taken together, our data demonstrated that VB, at the
conditions used in this study, exerted toxic effects (as it
was shown by reduced blastocyst formation) which could be
induced by its prooxidant activity. This prooxidant activity
could be due to an excessively high tested concentration as
observed by uptake data, by prolonged incubation time in
culture media (24 hours) used in the present study, in which
H
2
O
2
production is probably induced. Hydrogen peroxide
production was already demonstrated in previous studies in
which other polyphenols have been used in different cell
systems [61, 62, 81]. The H
2
O
2
production was assessed
by Odiatou et al. [81] on the two main olive polyphenols
(hydroxytyrosol and oleuropein) incubated in the culture
media and was observed as being dependent upon the
presence of sodium bicarbonate in the medium. Therefore,
polyphenols, normally considered as antioxidant, work as
prooxidants, when they are added in the commonly used
media, in standard culture conditions at high concentrations,
thus producing significant amounts of H
2
O
2
. Even for VB,
in the culture medium conditions used in this study, it could
be possible to speculate the same behaviour. In addition,
the possible presence of H
2
O
2
in the culture medium could
justify the increased oocyte intracellular ROS levels and CAT
activity.
5. Conclusions
In conclusion, VB, added at 𝜇-molar concentrations in
a continuative 24 hours IVM exposure protocol, acts as
a prooxidant molecule, by impairing oocyte bioenergetic
potential and oxidative status and embryo developmental
competence of prepubertal lamb oocytes. Applications of this
compound in oocyte or embryo culture systems could be
developed by evaluating its use at lower concentrations and
reduced exposure times.
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